Sensei Biotherapeutics (SNSE) Stock Forecast, Price Target & Predictions
SNSE Stock Forecast
Sensei Biotherapeutics stock forecast is as follows: an average price target of $5.50 (represents a 918.52% upside from SNSE’s last price of $0.54) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
SNSE Price Target
SNSE Analyst Ratings
Sensei Biotherapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 13, 2024 | Sudan Loganathan | Stephens | $5.00 | $1.57 | 218.47% | 825.93% |
Dec 13, 2022 | - | Citigroup | $6.00 | $1.74 | 244.83% | 1011.11% |
Sensei Biotherapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $5.00 |
Last Closing Price | $0.54 | $0.54 | $0.54 |
Upside/Downside | -100.00% | -100.00% | 825.93% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 13, 2024 | Stephens | - | Overweight | Initialise |
Dec 13, 2022 | Citigroup | - | Buy | Initialise |
Oct 03, 2022 | Oppenheimer | - | Outperform | Upgrade |
Sensei Biotherapeutics Financial Forecast
Sensei Biotherapeutics Revenue Forecast
Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|
Revenue | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
# Analysts | - | - | - |
Surprise % | - | - | - |
Sensei Biotherapeutics EBITDA Forecast
Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|
# Analysts | - | - | - |
EBITDA | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
Surprise % | - | - | - |
Sensei Biotherapeutics Net Income Forecast
Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|
# Analysts | - | - | - |
Net Income | - | - | - |
Avg Forecast | $-6.34M | $-7.83M | $-7.24M |
High Forecast | $-6.34M | $-7.32M | $-7.24M |
Low Forecast | $-6.34M | $-8.33M | $-7.24M |
Surprise % | - | - | - |
Sensei Biotherapeutics SG&A Forecast
Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|
# Analysts | - | - | - |
SG&A | - | - | - |
Avg Forecast | - | - | - |
High Forecast | - | - | - |
Low Forecast | - | - | - |
Surprise % | - | - | - |
Sensei Biotherapeutics EPS Forecast
Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|
# Analysts | - | - | - |
EPS | - | - | - |
Avg Forecast | $-0.25 | $-0.31 | $-0.29 |
High Forecast | $-0.25 | $-0.29 | $-0.29 |
Low Forecast | $-0.25 | $-0.33 | $-0.29 |
Surprise % | - | - | - |
SNSE Forecast FAQ
Is Sensei Biotherapeutics a good buy?
Yes, according to 3 Wall Street analysts, Sensei Biotherapeutics (SNSE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of SNSE's total ratings.
What is SNSE's price target?
Sensei Biotherapeutics (SNSE) average price target is $5.5 with a range of $5 to $6, implying a 918.52% from its last price of $0.54. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Sensei Biotherapeutics stock go up soon?
According to Wall Street analysts' prediction for SNSE stock, the company can go up by 918.52% (from the last price of $0.54 to the average price target of $5.5), up by 1011.11% based on the highest stock price target, and up by 825.93% based on the lowest stock price target.
Can Sensei Biotherapeutics stock reach $1?
SNSE's average twelve months analyst stock price target of $5.5 supports the claim that Sensei Biotherapeutics can reach $1 in the near future.
What are Sensei Biotherapeutics's analysts' financial forecasts?
SNSE's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-21.408M (high $-20.903M, low $-21.913M), average SG&A $0 (high $0, low $0), and average EPS is $-0.853 (high $-0.833, low $-0.873).